Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma

29 Mar 2022

Abstract excerpt

Background Lung cancer has been a prominent research focus in recent years due to its role in cancer-related fatalities globally, with lung adenocarcinoma (LUAD) being the most prevalent histological form. Nonetheless, no signature of lactate metabolism-related long non-coding RNAs (LMR-lncRNAs) has been developed for patients with LUAD. Accordingly, we aimed to develop a unique LMR-lncRNA signature to determine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35422758
DOI: 10.3389/fendo.2022.829175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung AdenocarcinomaPMID 35422758Read ↗

Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinomaSemantic proximity Read ↗

The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinomaSemantic proximity Read ↗

Lactate gene signature based on mitophagy predict the prognosis and immune response in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive analyses of metabolism-related lncRNA for LUADSemantic proximity Read ↗

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung AdenocarcinomaSemantic proximity Read ↗

A pathomics model for predicting lactate-related subtypes and their biological mechanisms in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinomaSemantic proximity Read ↗

Development of a Tumour Metabolism and Immune Microenvironment-Based Prognostic Model for Prognosis and Anti-Cancer Drug Response in Lung AdenocarcinomaSemantic proximity Read ↗

Prediction of Prognosis, Efficacy of Lung Adenocarcinoma by Machine Learning Model Based on Immune and Metabolic Related GenesSemantic proximity Read ↗

A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular CarcinomaSemantic proximity Read ↗

A novel Chemokine-related LncRNA signature predicts the prognosis and immunotherapy response in lung adenocarcinoma patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.